A Post-Approval, Single-Arm Study of the SYNERGY Stent System in China
About the study
A prospective, observational, single-arm, open-label, multicenter, post-approval study. To compile real-world clinical outcomes data for the SYNERGYTM MONORAILTM Everolimus-Eluting Platinum Chromium Coronary Stent System (SYNERGYTM Stent System) in real-world clinical practice in China.
Who can take part
You may be eligible to participate in the study if you meet the following criteria:
INCLUSION CRITERIA
Inclusion Criteria:
• Subject must be at least 18 years of age
- Subject understands and provides written informed consent
- Subject who is clinically indicated and will have an attempt of at least one SYNERGYTM stent OR Subject who is clinically indicated and was implanted with at least one SYNERGYTM stent
- Subject is willing to comply with all protocol-required follow-up evaluation
EXCLUSION CRITERIA
Exclusion Criteria:
Exclusion criteria are not required in this study which is an "all comers" study.
Study Locations
Enter your ZIP code/Postal code/PIN code to locate study sites near you:
How to Apply
Contact the study center to learn if this study is a good match for you.
Study’s details
Contition
Cardiovascular Diseases
Age (in years)
18+
Participants needed
2000
Est. Completion Date
Mar 31, 2028
Treatment type
Observational [Patient Registry]
Sponsor
Boston Scientific Corporation
ClinicalTrials.gov identifier
NCT03736226
Study number
S2424
Understanding Clinical Trials
Get answers to your questions about clinical trials.What is a clinical research?What does taking part in clinical trials involve?What should I ask the trial doctor?